Tag Archives: healthcare

Stop Demeaning the Healthy Dialogue Between Doctors and Drug Companies

Greenwood_Jim_BTN

A recent report in The Wall Street Journal entitled, “Even Cheap Meals Influence Doctors’ Drug Prescriptions, Study Suggests,” attempts to suggest an untoward influence resulting from drug company-sponsored physician education events. After reading the full study, it is clear that the WSJ author not only misinterpreted the conclusions of the study, but completely discounts the role that companies have in educating physicians about their products. Contrary to the author’s point, communication between drug companies and Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

PwC Report Finds Medicines Still Small Share of Overall Health Spending

medical_research

A new report from PwC’s Health Research Institute, Medical Cost Trend: Behind the Numbers 2017, offers evidence that medicines continue to represent a small portion of overall healthcare spending. The report highlighted that half of all medical costs come from hospital spending: 30 percent from hospital inpatient and 19 percent from hospital outpatient. Physicians account for another 30 percent, while prescription drugs account for 17 percent. With this breakdown comes the warning that it is Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Biotech Solutions for Zika

BIO_2016

The Zika virus epidemic continues to rage on. Just today, the WHO advised people in Zika affected countries (much of Latin America and the Caribbean) to consider delaying pregnancy, and emerging evidence suggests a broader range of possible complications for babies born to women infected with the virus than was first thought. Solutions are urgently needed, and biotechnology companies are hard at work to contribute. During a Wednesday at the 2016 BIO International Convention, attendees heard from Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , ,

Strategic Venture Investing by Large Pharma: Is “Smart Money” Right for Your Company

health care, medicine

The strategic venture arms of major biopharma companies like AbbVie, Amgen, Johnson & Johnson and Pfizer offer unique value propositions to early-stage companies and have the flexibility to shape unique deal structures for advancing these partnerships beyond traditional corporate venture capital models. Speakers at a 2016 BIO International Convention panel titled “Strategic Venture Investing by Large Pharma: Is ‘Smart Money’ Right for Your Company?” provided their about how these venture arms fuel innovation in the Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

Yoshinori Ohsumi, Ph.D., Receives 2016 Dr. Paul Janssen Award for Biomedical Research

BIO_2016

Johnson & Johnson presented cell biologist Yoshinori Ohsumi, Ph.D., of the Tokyo Institute of Technology, with the 2016 Dr. Paul Janssen Award for Biomedical Research for his discoveries in autophagy, spanning 27 years. Autophagy, a cell’s “self-eating” mechanism, is necessary for not only recycling nutrients, but for eliminating harmful proteins, organelles and even invasive bacteria. Dr. Ohsumi was honored today during a ceremony at the 2016 BIO International Convention in San Francisco. The award was named for Dr. Paul Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,